Alexa Hetzel, PA-C: Improving Vitiligo Facial Repigmentation with Topical JAK Inhibitors

Alexa Hetzel, PA-C, discusses the clinical efficacy of a non-steroidal topical JAK inhibitor that helps patients with vitiligo achieve significant facial repigmentation over 52 weeks. She emphasizes the importance of consistent twice-daily dosing and the provider’s role as a “cheerleader” to help patients manage the tedious repigmentation process and its impact on their mental health.